EGPA
Showing 1 - 25 of 32
Eosinophilic Granulomatosis With Polyangiitis Trial (SHR-1703, SHR-1703 Placebo)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- SHR-1703
- SHR-1703 Placebo
- (no location specified)
Jul 30, 2023
Eosinophilic Granulomatosis With Polyangiitis Trial in Tulsa, Norfolk (Depemokimab, Mepolizumab, Placebo matching mepolizumab)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Depemokimab
- +3 more
-
Tulsa, Oklahoma
- +1 more
Jul 19, 2022
ANCA-associated Vasculitis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis Trial in Toronto (vitamin D)
Active, not recruiting
- ANCA-associated Vasculitis
- +3 more
- vitamin D
-
Toronto, CanadaMount Sinai Hospital, Vasculitis clinic
Feb 15, 2022
Effectiveness of Eosinophilic Granulomatosis With Polyangiitis
Active, not recruiting
- Churg-Strauss Syndrome
-
Aichi, Japan
- +33 more
Sep 20, 2022
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Recruiting
- Cryoglobulinemic Vasculitis (CV)
- +9 more
-
Los Angeles, California
- +7 more
Jan 12, 2023
Autoantigens in EGPA and Severe Eosinophilic Asthma
Recruiting
- Churg-Strauss Syndrome
- +3 more
- Autoantibody ELISA
-
London, United Kingdom
- +1 more
Dec 10, 2020
Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial in Paris (Rituximab, Placebo-rituximab, Cyclophosphamide)
Completed
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Apr 13, 2021
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis Trial in United States
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- +6 more
- Naltrexone Hydrochloride
- Placebo Comparator
-
Boston, Massachusetts
- +6 more
Jan 25, 2022
Eosinophilic Asthma, EGPA - Eosinophilic Granulomatosis With Polyangiitis, Samter Triad Trial in Innsbruck (no intervention)
Recruiting
- Eosinophilic Asthma
- +4 more
- no intervention
-
Innsbruck, AustriaUniversity Clinic for Internal Medicine II
Sep 2, 2020
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Churg-Strauss Syndrome
-
San Diego, California
- +9 more
May 16, 2022
Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome Trial (NS-229, Placebo)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Churg-Strauss Syndrome
- NS-229
- Placebo
- (no location specified)
Sep 14, 2023
Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Feb 9, 2022
Prospective Longitudinal Cohort Study of Vasculitis Patients
Recruiting
- Vasculitis
- Data collection
- Biological samples and data collection
-
Paris, FranceService de médecine interne, Hôpital Cochin, AP-HP
Jan 24, 2022
Churg-Strauss Syndrome Trial in Worldwide (Mepolizumab, Prednisolone)
Active, not recruiting
- Churg-Strauss Syndrome
-
Denver, Colorado
- +31 more
Mar 11, 2021
One-Time DNA Study for Vasculitis
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
- +5 more
-
Los Angeles, California
- +13 more
May 16, 2022
Wegeners Granulomatosis (Granulomatosis With Polyangiitis), Microscopic Polyangiitis, Churg Strauss Syndrome (Eosinophilic
Recruiting
- Wegeners Granulomatosis (Granulomatosis With Polyangiitis)
- +6 more
-
San Francisco, California
- +37 more
Nov 4, 2022
Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Recruiting
- Takayasu's Arteritis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
VCRC Tissue Repository
Recruiting
- Aortitis
- +10 more
-
Boston, Massachusetts
- +7 more
Jan 25, 2022
NUCALA® Special Drug Use Investigation (EGPA, Long-term)
Active, not recruiting
- Churg-Strauss Syndrome
-
Tokyo, JapanGSK Investigational Site
Sep 7, 2018
Neutrophils as Prognostic Factors in Granulomatosis With
Completed
- Granulomatosis With Polyangiitis
- Blood samples and clinical data
- Blood sample
-
Paris, FranceCochin Hospital
Apr 13, 2021
Chronic Rhinosinusitis With Nasal Polyps Trial in Montreal (Dupilumab 300 MG in 2 ML Prefilled Syringe, Placebo, Mometasone
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Dupilumab 300 MG in 2 ML Prefilled Syringe
- +2 more
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Nov 10, 2022
ANCA Associated Vasculitis, Microscopic Polyangiitis, Churg-Strauss Syndrome Trial in United Kingdom (Hydroxychloroquine,
Recruiting
- ANCA Associated Vasculitis
- +3 more
- Hydroxychloroquine
- Placebo
-
Cardiff, United Kingdom
- +8 more
Mar 17, 2022
Real Life Experience Survey of Dupilumab in the Netherlands
Enrolling by invitation
- Severe Asthma
-
Rotterdam, NetherlandsFranciscus Gasthuis & Vlietland
Apr 16, 2022
Behcet's Disease, Churg-Strauss Syndrome, Giant Cell Arteritis Trial in Tampa
Completed
- Behcet's Disease
- +6 more
-
Tampa, FloridaUniversity of South Florida Data Management Coordinating Center
Oct 15, 2019